<i>KIR3DL3*001</i> tends to confer protection against AML (8.4% vs. 1.3%, <i>p</i> = 0.004, <i>Pc</i> = 0.06), whereas <i>KIR3DL3*009</i> conferred susceptibility to AML (29.3% vs. 47.1%, <i>p</i> = 0.001, <i>Pc =</i> 0.016). The gene discussed is KIR3DL3; the disease is acute myeloid leukemia.